Aneon Brillient, LLC

Reston, VA Part of Aneon Federal Solutions LLC

UEI
MS8HMAY331Q5
CAGE
9CUL5
Primary NAICS
541611 Administrative Management and General Management Consulting Services
SAM.gov registration
Active through

Company facts

FY2025 rankings
SBA certifications
8(a) Joint Venture
– · Ended
Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Asian-Pacific American Owned
  • Small Business Joint Venture
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
Show all 22
Corporate family
SAM.gov registration date
Physical address
1893 Metro Center Dr #210, Reston, VA 20190, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date -$7,648
FY2026 $5,054,275
FY2025 $6,672,120
FY2024 $12,423,907

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Health and Human Services $5,046,626

Contract vehicles

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Aneon Brillient, LLC, an SBA-certified 8(a) joint venture and minority-owned small disadvantaged business based in Reston, Virginia, operates as a prime contractor delivering professional services to the federal government across medical and scientific writing, quality assurance, administrative staffing, FOIA support, and technical services. The vendor is a subsidiary of Aneon Federal Solutions LLC and competes almost exclusively under 8(a) set-asides — 22 of 23 FDA contracts carry 8(a) sole-source or competitive set-aside designations, with one additional direct 8(a) award carrying no formal set-aside label.

Aneon Brillient's customer concentration is extreme: the Food and Drug Administration funds 23 of 24 prime awards for a combined potential value of $29.6 million, representing 100% of customer dollars across the portfolio. Recent capability work centers on specialized support to FDA centers including the Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), and Center for Devices and Radiological Health (CDRH). Representative engagements include a $4.3 million direct 8(a) CDER professional services contract awarded August 2, 2024 (labor-hour, base 12 months plus 9-month option, performance in Calverton, Maryland); a $4.2 million direct 8(a) CDER supply chain technical support contract awarded August 28, 2025 (labor-hour, 9.5-month base with two 12-month options, performance in Beltsville, Maryland); a $2.1 million direct 8(a) CDER medical and scientific writing contract awarded August 21, 2024 (labor-hour, four-year term, performance in Calverton, Maryland); and a $1.9 million direct 8(a) Oncology Center of Excellence professional services contract awarded August 12, 2026 (labor-hour, one-year term, performance in Silver Spring, Maryland). Smaller orders spanning quality management, FOIA support, database administration, and communications support round out the FDA work.

Activity spiked in 2024 with 18 awards, declined to 5 in 2025, and has slowed to 1 in 2026 — a pattern reflecting contract award timing at FDA rather than capacity growth. Nine awards carrying combined potential value of $14.9 million reach ultimate completion within the next twenty-four months, creating both recompete exposure and pipeline opportunity for the vendor. Obligated dollars to date total $23.9 million (81% of potential value), indicating active execution across the portfolio.

Across SCI-reportable prime contracts, Aneon Brillient invoiced $3.5 million in FY2024 across 15.0 FTEs and $8.3 million in FY2025 across 35.1 FTEs — reflecting staffing ramp on growing FDA engagements. Government-paid hourly rates on SCI-reportable work median around $111.74 per hour, with junior labor in the $77.89 range and senior positions through $151.61 per hour. The vendor self-performs all labor with no subcontractor engagement reported across SCI records — 0% sub-hours share — positioning Aneon Brillient as a direct-delivery prime rather than a subcontracting feeder for larger contractors.

On April 16, 2025, the GSA Federal Acquisition Service awarded Aneon Brillient a seat on the OASIS+ 8(a) competitive multiple-award IDIQ with performance through April 15, 2030. This vehicle carries a multi-billion-dollar ceiling and positions the vendor to pursue task orders across federal agencies beyond FDA, though pipeline activity outside HHS remains absent from the current award portfolio. The vendor's 8(a) certification expires August 7, 2026.

Quick answers

Is Aneon Brillient, LLC registered in SAM.gov?

Yes. Aneon Brillient, LLC's SAM.gov registration is active through December 5, 2026.

Which contract vehicles does Aneon Brillient, LLC hold?

Aneon Brillient, LLC holds a place on 1 federal contract vehicle: OASIS+8A.

How much has Aneon Brillient, LLC received in federal contracts?

Federal contracts obligated $6,672,120 to Aneon Brillient, LLC in fiscal year 2025 and $24,142,654 in fiscal years 2023 through 2027.

How does Aneon Brillient, LLC rank among federal contractors?

Aneon Brillient, LLC ranked #9 in PSC R610 in FY2025.

What is Aneon Brillient, LLC's most recent federal award?

Aneon Brillient, LLC's most recent federal contract award is Direct 8(a) award, stand-alone, labor-hour (LH) type contract for food and drug administration for oncology center of… (75F40126C00027), from Food and Drug Administration, on August 12, 2026.

On GovTribe

See Aneon Brillient, LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors